Did you fracture your tibia and undergo surgery to stabilize the bone?

A nationwide FDA regulated IDE clinical research study is underway for patients with a recent tibial fracture.

Ask your doctor about participating in the TRUST Study: A trial to evaluate ultrasound in the treatment of tibial fractures.

EXOGEN°

Ultrasound Bone Healing System

You are not alone:

Tibial fractures are the most common long bone fractures. In fact, nearly 500,000 occur every year in the United States.

The goal of using anintramedullary (IIM) nail during surgery is to stabilize the fracture to better allow the bone to heal.

Unfortunately, not all patients heal properly or at the same rate post surgery, so there is a need to investigate additional therapies.

What is EXOGEN° Ultrasound?

• Low intensity pulsed ultrasound is sent through a small transducer that is placed on your skin at your fracture site for only 20 minutes a day

• Ultrasound waves activate cells at the fracture site to increase natural growth factors that are essential to bone healing.

• Patients do not feel or hear the ultrasound waves.

• EXOGEN Ultrasound has been FDA approved to accelerate healing in certain fresh bone fractures and fractures that will not heal on their own.

The primary objective of the TRUST Study is to determine if EXOGEN Ultrasound is an effective treatment to accelerate the healing and return to function in patients who have received an IM nail during surgery for a fractured tibia. The FDA has not yet approved EXOGEN Ultrasound for the treatment of surgically treated fresh tibial fractures. This noninvasive device is considered investigational (experimental) for this purpose.

If you think you may be eligible for study participation or want more information about becoming a research hero, please call us at 954-400-5544 fill out the Request an Appointment form above, or email us at info@shrockresearch.com.

Share